agilon health, inc. (AGL)

agilon health Stock Forecast

Stock Price Forecast

The 10 analysts that cover agilon health stock have a consensus rating of "Hold" and an average price target of $55.68, which forecasts a 79.96% increase in the stock price over the next year. The lowest target is $12.5 and the highest is $187.5.

Price Target: $55.68 (+79.96%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$12.5	$55.68	$35	$187.5
Change	-59.60%	+79.96%	+13.12%	+506.01%

Analyst Ratings

The average analyst rating for agilon health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	1	1	1	1	1	1
Buy	3	3	3	2	2	2
Hold	15	13	13	10	10	8
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	20	18	18	14	14	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bill Sutherland Benchmark	Benchmark	Strong Buy Maintains $1.5 → $13	Strong Buy	Maintains	$1.5 → $13	-57.98%	Apr 2, 2026
Daniel Grosslight Citigroup	Citigroup	Hold Maintains $21 → $19	Hold	Maintains	$21 → $19	-39.40%	Mar 3, 2026
Stephen Baxter Wells Fargo	Wells Fargo	Buy Maintains $25 → $38	Buy	Maintains	$25 → $38	+21.20%	Feb 27, 2026
Andrew Mok Barclays	Barclays	Sell Maintains $25 → $13	Sell	Maintains	$25 → $13	-59.60%	Feb 27, 2026
David Larsen BTIG	BTIG	Hold Suspends n/a	Hold	Suspends	n/a	n/a	Dec 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

5.51B

Decreased by -7.14%

from 5.93B

Revenue Next Year

5.74B

Increased by 4.23%

from 5.51B

EPS This Year

-5.93

from -23.63

EPS Next Year

-4.62

from -5.93

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.52B	2.39B	4.32B	6.06B	5.93B	5.51B	5.74B
Revenue Growth	24.88%	56.97%	80.74%	40.41%	-2.11%	-7.14%	4.23%
EPS	-27.25	-6.53	-16.05	-15.83	-23.63	-5.93	-4.62
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	18	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	5.8B	6.4B
Avg	5.5B	5.7B
Low	5.3B	5.1B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	-2.7%	15.4%
Avg	-7.1%	4.2%
Low	-10.6%	-7.6%

EPS Forecast

EPS	2026	2027	2028
High	-3.82	-1.35
Avg	-5.93	-4.62
Low	-10.22	-7.21

EPS Growth

EPS Growth	2026	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.